Complexes between activated protein C and protein C inhibitor measured with a new method: Comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis

Thrombosis and Haemostasis

Volumn 86, Issue 6, 2001, Pages 1400-1408

  Strandberg, K ^a   Astermark, J ^a   Bjorgell O ^a   Becker, C ^a   Nilsson, P E ^a   Stenflo, J ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APC PCI complex; Case control study; Deep vein thrombosis; Hypercoagulability markers; Immunofluorometric assay

Indexed keywords

ACTIVATED PROTEIN C; D DIMER; FIBRIN; MONOMER; PLASMINOGEN ACTIVATOR INHIBITOR 3; THROMBIN ANTITHROMBIN COMPLEX;

AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; HYPERCOAGULABILITY; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

EID: 0035654943     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616742     Document Type: Article

References (33)

1. The diagnosis of clinically suspected venous thrombosis
2. A new scoring system for the detailed description of the distribution and thrombotic burden in deep leg vein thrombosis
3. D-dimer testing in the diagnosis of acute venous thromboembolism
4. Exclusion of deep venous thrombosis with D-dimer testing
5. D-dimers, thrombin-antithrombin III complexes and prothrombin fragments 1+2: Diagnostic value in clinically suspected deep vein thrombosis
6. D-dimer and TAT measurement in patients with deep venous thrombosis: Utility in diagnosis and judgement of anticoagulant treatment effectiveness
7. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state
8. The protein C anticoagulant system
9. Endothelial protein C receptor
10. Protein C inhibitor. Purification from human plasma and characterization
11. Activated protein C inhibitor
12. Physiological inhibition of human activated protein C by α-1-antitrypsin
13. Determination of plasma protein C inhibitor and of two activated protein C inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease
14. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism
15. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states
16. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: Use of a catcher antibody specific for the complexed/cleaved form of the inhibitor
17. Activated protein C-protein C inhibitor complex formation: Characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop
18. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's
19. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen
20. Mutation in blood coagulation factor V associated with resistance to activated protein C
21. A common genetic variation in the 3′-unstranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
22. Software for illustrative presentation of basic clinical characteristics of laboratory tests - Graph ROC for Windows
23. Thrombophilia as a multigenic disease
24. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden thrombophilia study)
25. Strategies for the diagnosis of deep vein thrombosis and pulmonary embolism
26. Isolated internal iliac thrombosis: A case report
27. The frequency and significance of postoperative plantar vein thrombosis judged by the 125I-fibrinogen test
28. Isolated nonfilling of contrast in deep leg vein segments seen on phlebography, and a comparison with color Doppler ultrasound, to assess the incidence of deep leg vein thrombosis
29. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
30. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons
31. Serpin biosynthesis, clearance and receptors
32. The molecular basis of fibrin
33. Is embolic risk conditioned by location of deep venous thrombosis?